Literature DB >> 32472441

TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.

Antonio Travaglino1, Antonio Raffone2, Annarita Gencarelli1, Antonio Mollo3, Maurizio Guida3, Luigi Insabato1, Angela Santoro4, Gian Franco Zannoni4, Fulvio Zullo3.   

Abstract

In 2013, The Cancer Genome Atlas (TCGA) Research Network found four novel prognostic subgroups of endometrial carcinoma: POLE/ultramutated (POLE), microsatellite-instable/hypermutated (MSI), copy-number-low/TP53-wild-type (CNL), and copy-number-highTP53-mutant (CNH). However, poor is known regarding uncommon histotypes of endometrial cancer. We aimed to assess the genetic profile of uterine carcinosarcoma (UCS) on the light of these findings. A systematic review and meta-analysis was performed through electronic databases searching (up to July 2019). All studies assessing UCS series for the TCGA classification were included. For each TCGA subgroup, pooled prevalence on the total UCS number was calculated. Four studies with 231 patients were included. Pooled prevalence of the TCGA subgroups were: 5.3% for the POLE subgroup, 7.3% for the MSI subgroup, 73.9% for the CNH subgroup, 13.5% for the CNL subgroup. The CNH subgroup predominates in UCS, while subgroups with high mutational load (POLE and MSI) are less common. UCS appears as a preferential evolution of CNH carcinomas.

Entities:  

Keywords:  Cancer; Endometrium; PROMISE; Prognosis; Risk assessment; Treatment

Mesh:

Substances:

Year:  2020        PMID: 32472441     DOI: 10.1007/s12253-020-00829-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  46 in total

Review 1.  Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review.

Authors:  Antonio Travaglino; Antonio Raffone; Gabriele Saccone; Luigi Insabato; Antonio Mollo; Giuseppe De Placido; Fulvio Zullo
Journal:  Acta Obstet Gynecol Scand       Date:  2019-03-18       Impact factor: 3.636

2.  Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer.

Authors:  Antonio Travaglino; Antonio Raffone; Gabriele Saccone; Caterina De Luca; Antonio Mollo; Massimo Mascolo; Giuseppe De Placido; Luigi Insabato; Fulvio Zullo
Journal:  Am J Clin Pathol       Date:  2019-04-02       Impact factor: 2.493

3.  Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.

Authors:  Aline Talhouk; Melissa K McConechy; Samuel Leung; Winnie Yang; Amy Lum; Janine Senz; Niki Boyd; Judith Pike; Michael Anglesio; Janice S Kwon; Anthony N Karnezis; David G Huntsman; C Blake Gilks; Jessica N McAlpine
Journal:  Cancer       Date:  2017-01-06       Impact factor: 6.860

4.  Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.

Authors:  C Blake Gilks; Esther Oliva; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

5.  Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.

Authors:  Tjalling Bosse; Remi A Nout; Jessica N McAlpine; Melissa K McConechy; Heidi Britton; Yaser R Hussein; Carlene Gonzalez; Raji Ganesan; Jane C Steele; Beth T Harrison; Esther Oliva; August Vidal; Xavier Matias-Guiu; Nadeem R Abu-Rustum; Douglas A Levine; C Blake Gilks; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-05       Impact factor: 6.394

6.  Histotype-genotype correlation in 36 high-grade endometrial carcinomas.

Authors:  Lien N Hoang; Melissa K McConechy; Martin Köbel; Guangming Han; Marjan Rouzbahman; Ben Davidson; Julie Irving; Rola H Ali; Sam Leung; Jessica N McAlpine; Esther Oliva; Marisa R Nucci; Robert A Soslow; David G Huntsman; C Blake Gilks; Cheng-Han Lee
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

7.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

8.  Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.

Authors:  Ellen Stelloo; Remi A Nout; Elisabeth M Osse; Ina J Jürgenliemk-Schulz; Jan J Jobsen; Ludy C Lutgens; Elzbieta M van der Steen-Banasik; Hans W Nijman; Hein Putter; Tjalling Bosse; Carien L Creutzberg; Vincent T H B M Smit
Journal:  Clin Cancer Res       Date:  2016-03-22       Impact factor: 12.531

Review 9.  The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.

Authors:  Jessica McAlpine; Alicia Leon-Castillo; Tjalling Bosse
Journal:  J Pathol       Date:  2018-02-28       Impact factor: 7.996

10.  A clinically applicable molecular-based classification for endometrial cancers.

Authors:  A Talhouk; M K McConechy; S Leung; H H Li-Chang; J S Kwon; N Melnyk; W Yang; J Senz; N Boyd; A N Karnezis; D G Huntsman; C B Gilks; J N McAlpine
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

View more
  18 in total

1.  Incentive Nursing can Effectively Improve the ESCA Level of Patients with Endometrial Cancer after Laparoscopic Hysterectomy.

Authors:  Ju Zong; Liping Chen; Jie Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-12       Impact factor: 2.650

Review 2.  Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.

Authors:  Antonio Travaglino; Antonio Raffone; Diego Raimondo; Damiano Arciuolo; Giuseppe Angelico; Michele Valente; Giulia Scaglione; Nicoletta D'alessandris; Paolo Casadio; Frediano Inzani; Antonio Mollo; Angela Santoro; Renato Seracchioli; Gian Franco Zannoni
Journal:  Int J Gynaecol Obstet       Date:  2021-10-11       Impact factor: 4.447

Review 3.  Cancer Risk and Mutational Patterns Following Organ Transplantation.

Authors:  Yangyang Shen; Di Lian; Kai Shi; Yuefeng Gao; Xiaoxiang Hu; Kun Yu; Qian Zhao; Chungang Feng
Journal:  Front Cell Dev Biol       Date:  2022-06-28

4.  Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.

Authors:  Allison Staley; Katherine Tucker; Yajie Yin; Xin Zhang; Yali Fan; Yingao Zhang; Ziwei Fang; Wenchuan Sun; Hongyan Suo; Xiaoling Zhao; Ziyi Zhao; Varun Vijay Prabhu; Joshua E Allen; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Cancer Res       Date:  2021-11-15       Impact factor: 6.166

5.  Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer.

Authors:  Vanessa M López-Ozuna; Liron Kogan; Mahmood Y Hachim; Emad Matanes; Ibrahim Y Hachim; Cristina Mitric; Lauren Liu Chen Kiow; Susie Lau; Shannon Salvador; Amber Yasmeen; Walter H Gotlieb
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

Review 6.  Metformin Intervention-A Panacea for Cancer Treatment?

Authors:  Angelika Buczyńska; Iwona Sidorkiewicz; Adam Jacek Krętowski; Monika Zbucka-Krętowska; Agnieszka Adamska
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

Review 7.  Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian).

Authors:  Camille Evrard; Jérôme Alexandre
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 8.  New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.

Authors:  Angela Santoro; Giuseppe Angelico; Antonio Travaglino; Frediano Inzani; Damiano Arciuolo; Michele Valente; Nicoletta D'Alessandris; Giulia Scaglione; Vincenzo Fiorentino; Antonio Raffone; Gian Franco Zannoni
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 9.  Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.

Authors:  Seiichi Mori; Osamu Gotoh; Kazuma Kiyotani; Siew Kee Low
Journal:  J Hum Genet       Date:  2021-06-07       Impact factor: 3.172

Review 10.  Impact of adenomyosis on the prognosis of patients with endometrial cancer.

Authors:  Diego Raimondo; Antonio Raffone; Antonio Travaglino; Manuela Maletta; Paolo Casadio; Marco Ambrosio; Anna Chiara Aru; Angela Santoro; Gian Franco Zannoni; Luigi Insabato; Antonio Mollo; Fulvio Zullo; Renato Seracchioli
Journal:  Int J Gynaecol Obstet       Date:  2021-07-18       Impact factor: 4.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.